Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
BMJ Open
|
February 23, 2022
Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study
Ciaran N Kohli-Lynch, Agnes Erzse, B Rayner, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 11, 2020
The clinical utility of apoB versus LDL-C/non-HDL-C
Ciaran N Kohli-Lynch, George Thanassoulis, Andrew E Moran, et al.
Administration and Policy in Mental Health
|
January 17, 2022
Trial-Based Economic Evaluations of Supported Employment for Adults with Severe Mental Illness: A Systematic Review
Katherine Zheng, Brocha Z Stern, Q Eileen Wafford, et al.
JAMA
|
April 8, 2026
Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy
Samuel Luebbe, Allan D Sniderman, Andrew E Moran, et al.
Health Policy and Planning
|
January 22, 2024
Extended cost-effectiveness analysis of interventions to improve uptake of diabetes services in South Africa
Heather L Fraser, Isabelle Feldhaus, Ijeoma P Edoka, et al.
Circulation
|
March 7, 2022
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
Ciaran N Kohli-Lynch, James Lewsey, Kathleen A Boyd, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 17, 2016
Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model
Nathalie Moise, Chen Huang, Anthony Rodgers, et al.
Journal of the American College of Cardiology
|
November 12, 2021
Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults
Ciaran N Kohli-Lynch, Brandon K Bellows, Yiyi Zhang, et al.
JAMA Cardiology
|
January 8, 2025
Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population
Ciaran N Kohli-Lynch, Andrew E Moran, Dhruv S Kazi, et al.
JAMA Cardiology
|
August 29, 2019
Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk
Ciaran N Kohli-Lynch, Brandon K Bellows, George Thanassoulis, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
BMJ Open
|
February 23, 2022
Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study
Ciaran N Kohli-Lynch, Agnes Erzse, B Rayner, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 11, 2020
The clinical utility of apoB versus LDL-C/non-HDL-C
Ciaran N Kohli-Lynch, George Thanassoulis, Andrew E Moran, et al.
Administration and Policy in Mental Health
|
January 17, 2022
Trial-Based Economic Evaluations of Supported Employment for Adults with Severe Mental Illness: A Systematic Review
Katherine Zheng, Brocha Z Stern, Q Eileen Wafford, et al.
JAMA
|
April 8, 2026
Cost-Effectiveness of ApoB, Non-HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy
Samuel Luebbe, Allan D Sniderman, Andrew E Moran, et al.
Health Policy and Planning
|
January 22, 2024
Extended cost-effectiveness analysis of interventions to improve uptake of diabetes services in South Africa
Heather L Fraser, Isabelle Feldhaus, Ijeoma P Edoka, et al.
Circulation
|
March 7, 2022
Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease
Ciaran N Kohli-Lynch, James Lewsey, Kathleen A Boyd, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 17, 2016
Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model
Nathalie Moise, Chen Huang, Anthony Rodgers, et al.
Journal of the American College of Cardiology
|
November 12, 2021
Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults
Ciaran N Kohli-Lynch, Brandon K Bellows, Yiyi Zhang, et al.
JAMA Cardiology
|
January 8, 2025
Cost-Effectiveness of a Polypill for Cardiovascular Disease Prevention in an Underserved Population
Ciaran N Kohli-Lynch, Andrew E Moran, Dhruv S Kazi, et al.
JAMA Cardiology
|
August 29, 2019
Cost-effectiveness of Low-density Lipoprotein Cholesterol Level-Guided Statin Treatment in Patients With Borderline Cardiovascular Risk
Ciaran N Kohli-Lynch, Brandon K Bellows, George Thanassoulis, et al.
Page
of 2